# Neuralink — Healthcare Investment Intelligence

> medical_device · Series C+. MedFuel Intel profile as of 2026-06-12.

Neuralink is an American neurotechnology company founded in 2016 by Elon Musk that develops implantable brain-computer interfaces (BCIs) to treat neurological conditions. The company successfully implanted its N1 device in human patients in 2024 and 2025, demonstrating the ability to translate neural signals into digital commands for individuals with paralysis and spinal cord injuries.

## Key facts (as of 2026-06-12)
- Sector: medical_device
- Stage: Series C+
- Website: https://neuralink.com

## MedFuel assessment
- Intelligence score: 0/100
- Analyses: 0
- Sentiment trend: stable

---
Source: MedFuel Intel — https://medfuelintel.com/company/neuralink-8. Figures reflect MedFuel's analysis; verify against primary sources (SEC, FDA, ClinicalTrials.gov) before any investment decision.